US Patent 8722064 Synthetic glucopyranosyl lipid adjuvants
Patent 8722064 was granted and assigned to Infectious Disease Research Institute on May, 2014 by the United States Patent and Trademark Office.
All edits
Edits on 19 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 2 Dec, 2023
Golden AI
Edits made to:
Article (+135 characters)
Article
Patent abstract
Compounds, particularly, glucopyranosyl lipid adjuvant (GLA) compounds, having the following structure (I) are provided:
Edits on 25 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Darrick Carter0
Steven G. Reed0
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08722064 Synthetic glucopyranosyl lipid adjuvants US Patent 8722064 Synthetic glucopyranosyl lipid adjuvants
Infobox
Patent Number
08722064
Patent Number
8722064
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08722064 Synthetic glucopyranosyl lipid adjuvants
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08722064
Date of patent
May 13, 2014
Patent application number
12794336
Date Filed
June 4, 2010
Patent primary examiner
Find more entities like US Patent 8722064 Synthetic glucopyranosyl lipid adjuvants
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
